These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


135 related items for PubMed ID: 1893087

  • 1. Renal allograft platelet activating factor synthesis during acute cellular rejection.
    Mangino MJ, Anderson CB, Murphy MK, Turk J.
    J Lipid Mediat; 1991; 4(1):69-81. PubMed ID: 1893087
    [Abstract] [Full Text] [Related]

  • 2. Platelet-activating factor in human normal tears.
    Okumura N, Kojima K, Hashida M, Koura Y, Fukushima A, Ueno H.
    Curr Eye Res; 2005 Oct; 30(10):891-6. PubMed ID: 16251126
    [Abstract] [Full Text] [Related]

  • 3. Hyperacute renal allograft rejection in the rabbit. The role of platelet-activating factor and of cationic proteins derived from polymorphonuclear leukocytes and from platelets.
    Ito S, Camussi G, Tetta C, Milgrom F, Andres G.
    Lab Invest; 1984 Aug; 51(2):148-61. PubMed ID: 6379289
    [Abstract] [Full Text] [Related]

  • 4. A competitive receptor binding assay for platelet-activating factor (PAF): quantification of PAF in rat brain.
    Tiberghien C, Laurent L, Junier MP, Dray F.
    J Lipid Mediat; 1991 Aug; 3(3):249-66. PubMed ID: 1773028
    [Abstract] [Full Text] [Related]

  • 5. Quantification of distinct molecular species of platelet activating factor in ulcerative colitis.
    Thyssen E, Turk J, Bohrer A, Stenson WF.
    Lipids; 1996 Mar; 31 Suppl():S255-9. PubMed ID: 8729129
    [Abstract] [Full Text] [Related]

  • 6. Characterization of platelet-activating factor receptors on canine T lymphocytes.
    Mangino MJ, Murphy MK, Weiss A, Anderson CB.
    J Immunol; 1993 Nov 15; 151(10):5310-8. PubMed ID: 8228226
    [Abstract] [Full Text] [Related]

  • 7. Effects of the thromboxane synthesis inhibitor CGS-12970 on experimental acute renal allograft rejection.
    Mangino MJ, Brunt EM, Von Doersten P, Anderson CB.
    J Pharmacol Exp Ther; 1989 Jan 15; 248(1):23-8. PubMed ID: 2643702
    [Abstract] [Full Text] [Related]

  • 8. Quantification of distinct molecular species of the 2-lyso metabolite of platelet-activating factor by gas chromatography-negative-ion chemical ionization mass spectrometry.
    Turk J, Bohrer A, Stump WT, Ramanadham S, Mangino MJ.
    J Chromatogr; 1992 Mar 27; 575(2):183-96. PubMed ID: 1629294
    [Abstract] [Full Text] [Related]

  • 9. Biosynthesis of platelet-activating factor. VI. Precursor of platelet-activating factor and acetyltransferase activity in isolated rat kidney cells.
    Pirotzky E, Ninio E, Bidault J, Pfister A, Benveniste J.
    Lab Invest; 1984 Nov 27; 51(5):567-72. PubMed ID: 6492758
    [Abstract] [Full Text] [Related]

  • 10. Pharmacokinetic analysis of platelet-activating factor in the tears of guinea pigs with allergic conjunctivitis.
    Okumura N, Fukushima A, Igarashi A, Sumi T, Yamagishi T, Ueno H.
    J Ocul Pharmacol Ther; 2006 Oct 27; 22(5):347-52. PubMed ID: 17076629
    [Abstract] [Full Text] [Related]

  • 11. Role of platelet activating factor in kidney transplant rejection in the rat.
    Butterly DW, Spurney RF, Ruiz P, Pirotzky E, Braquet P, Coffman TM.
    Kidney Int; 1995 Aug 27; 48(2):337-43. PubMed ID: 7564100
    [Abstract] [Full Text] [Related]

  • 12. Species-specific variations in the molecular heterogeneity of the platelet-activating factor.
    Ramesha CS, Pickett WC.
    J Immunol; 1987 Mar 01; 138(5):1559-63. PubMed ID: 3100641
    [Abstract] [Full Text] [Related]

  • 13. Human endothelial cells are target for platelet-activating factor. II. Platelet-activating factor induces platelet-activating factor synthesis in human umbilical vein endothelial cells.
    Heller R, Bussolino F, Ghigo D, Garbarino G, Pescarmona G, Till U, Bosia A.
    J Immunol; 1992 Dec 01; 149(11):3682-8. PubMed ID: 1431139
    [Abstract] [Full Text] [Related]

  • 14. High affinity specific binding sites for tritiated platelet-activating factor in canine platelet membranes: counterparts of platelet-activating factor receptors mediating platelet aggregation.
    Tahraoui L, Floch A, Mondot S, Cavero I.
    Mol Pharmacol; 1988 Aug 01; 34(2):145-51. PubMed ID: 2842653
    [Abstract] [Full Text] [Related]

  • 15. An anti-platelet activating factor antibody and its effects on platelet aggregation.
    Tatsumi N, Terano Y, Hashimoto K, Hiyoshi M, Matsuura S.
    Osaka City Med J; 1993 Nov 01; 39(2):167-74. PubMed ID: 8183536
    [Abstract] [Full Text] [Related]

  • 16. Potential angiogenic role of platelet-activating factor in human breast cancer.
    Montrucchio G, Sapino A, Bussolati B, Ghisolfi G, Rizea-Savu S, Silvestro L, Lupia E, Camussi G.
    Am J Pathol; 1998 Nov 01; 153(5):1589-96. PubMed ID: 9811351
    [Abstract] [Full Text] [Related]

  • 17. Isolation and identification of embryo-derived platelet-activating factor in mice.
    Kodama H, Muto H, Maki M.
    Nihon Sanka Fujinka Gakkai Zasshi; 1989 Jul 01; 41(7):899-906. PubMed ID: 2794622
    [Abstract] [Full Text] [Related]

  • 18. Biosynthesis of platelet-activating factor in cultured mast cells. Involvement of the CoA-independent transacylase demonstrated by analysis of the molecular species of platelet-activating factor.
    Colard O, Bidault J, Breton M, Ninio E.
    Eur J Biochem; 1993 Sep 15; 216(3):835-40. PubMed ID: 8404903
    [Abstract] [Full Text] [Related]

  • 19. Acetyl-CoA:1-O-alkyl-sn-glycero-3-phosphocholine acetyltransferase (lyso-PAF AT) activity in cortical and medullary human renal tissue.
    Nomikos TN, Iatrou C, Demopoulos CA.
    Eur J Biochem; 2003 Jul 15; 270(14):2992-3000. PubMed ID: 12846832
    [Abstract] [Full Text] [Related]

  • 20. Decrease of ciliary beat frequency by platelet activating factor: protective effect of ketotifen.
    Kahhak L, Roche A, Dubray C, Arnoux C, Benveniste J.
    Inflamm Res; 1996 May 15; 45(5):234-8. PubMed ID: 8737746
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.